BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11446742)

  • 1. Mutation of the invariant chain transmembrane region inhibits II degradation, prolongs association with MHC class II, and selectively disrupts antigen presentation.
    Frauwirth K; Shastri N
    Cell Immunol; 2001 May; 209(2):97-108. PubMed ID: 11446742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation.
    Bertolino P; Staschewski M; Trescol-Biémont MC; Freisewinkel IM; Schenck K; Chrétien I; Forquet F; Gerlier D; Rabourdin-Combe C; Koch N
    J Immunol; 1995 Jun; 154(11):5620-9. PubMed ID: 7751615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner.
    Gautam AM; Yang M; Milburn PJ; Baker R; Bhatnagar A; McCluskey J; Boston T
    J Immunol; 1997 Sep; 159(6):2782-8. PubMed ID: 9300699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells.
    Adorini L; Guéry JC; Fuchs S; Ortiz-Navarrete V; Hämmerling GJ; Momburg F
    J Immunol; 1993 Oct; 151(7):3576-86. PubMed ID: 7690807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
    Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
    J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.
    Eastman S; Deftos M; DeRoos PC; Hsu DH; Teyton L; Braunstein NS; Hackett CJ; Rudensky A
    Eur J Immunol; 1996 Feb; 26(2):385-93. PubMed ID: 8617308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
    Brocke P; Armandola E; Garbi N; Hämmerling GJ
    Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
    Adams S; Humphreys RE
    Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
    Swier K; Miller J
    J Immunol; 1995 Jul; 155(2):630-43. PubMed ID: 7608541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide.
    van Bergen J; Camps M; Offringa R; Melief CJ; Ossendorp F; Koning F
    Cancer Res; 2000 Nov; 60(22):6427-33. PubMed ID: 11103809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell recognition of flanking residues of murine invariant chain-derived CLIP peptide bound to MHC class II.
    Naujokas MF; Southwood S; Mathies SJ; Appella E; Sette A; Miller J
    Cell Immunol; 1998 Aug; 188(1):49-54. PubMed ID: 9743557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytoplasmic tail of invariant chain modulates antigen processing and presentation.
    Gregers TF; Nordeng TW; Birkeland HC; Sandlie I; Bakke O
    Eur J Immunol; 2003 Feb; 33(2):277-86. PubMed ID: 12548558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation of antigens internalized through the B cell receptor requires newly synthesized MHC class II molecules.
    Forquet F; Barois N; Machy P; Trucy J; Zimmermann VS; Leserman L; Davoust J
    J Immunol; 1999 Mar; 162(6):3408-16. PubMed ID: 10092796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-terminal extension of the MHC class II-associated invariant chain by an antigenic sequence triggers activation of naive T cells.
    Sponaas A; Carstens C; Koch N
    Gene Ther; 1999 Nov; 6(11):1826-34. PubMed ID: 10602378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
    Thayer WP; Ignatowicz L; Weber DA; Jensen PE
    J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MHC class II-associated invariant chain: a molecule with multiple roles in MHC class II biosynthesis and antigen presentation to CD4+ T cells.
    Bertolino P; Rabourdin-Combe C
    Crit Rev Immunol; 1996; 16(4):359-79. PubMed ID: 8954255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The invariant chain transports TNF family member CD70 to MHC class II compartments in dendritic cells.
    Zwart W; Peperzak V; de Vries E; Keller AM; van der Horst G; Veraar EA; Geumann U; Janssen H; Janssen L; Naik SH; Neefjes J; Borst J
    J Cell Sci; 2010 Nov; 123(Pt 21):3817-27. PubMed ID: 20971706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.
    Teyton L; O'Sullivan D; Dickson PW; Lotteau V; Sette A; Fink P; Peterson PA
    Nature; 1990 Nov; 348(6296):39-44. PubMed ID: 2234057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.